Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus

Background:Dysplasia is a marker of cancer risk in Barrett's oesophagus (BO), but this risk is variable and diagnosis is subject to inter-observer variability. Cancer risk in BO is increased when chromosomal instability is present. Nucleotyping (NT) is a new method that uses high-resolution digital images of nuclei to assess chromatin organisation both quantitatively and qualitatively. We aimed to evaluate NT as a marker of dysplasia in BO and compare with image cytometric DNA analysis (ICM).Methods:In all, 120 patients with BO were studied. The non-dysplastic group (n=60) had specialised intestinal metaplasia only on two consecutive endoscopies after 51 months median follow-up (IQR=25–120 months). The dysplastic group (n=60) had high-grade dysplasia or carcinoma in situ. The two groups were then randomly assigned to a training set and a blinded test set in a 1 : 1 ratio. Image cytometric DNA analysis and NT was then carried out on Feulgen-stained nuclear monolayers.Results:The best-fit model for NT gave a correct classification rate (CCR) for the training set of 83%. The test set was then analysed using the same textural features and yielded a CCR of 78%. Image cytometric DNA analysis alone yielded a CCR of 73%. The combination of ICM and NT yielded a CCR of 84%.Conclusion:Nucleotyping differentiates dysplastic and non-dysplastic BO, with a greater sensitivity than ICM. A combination score based on both techniques performed better than either test in isolation. These data demonstrate that NT/ICM on nuclear monolayers is a very promising single platform test of genomic instability, which may aid pathologists in the diagnosis of dysplasia and has potential as a biomarker in BO.

[1]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[2]  K. Abrams,et al.  Meta analysis: cancer risk in Barrett’s oesophagus , 2007, Alimentary pharmacology & therapeutics.

[3]  Fritz Albregtsen,et al.  Prognostic Classification of Early Ovarian Cancer Based on very Low Dimensionality Adaptive Texture Feature Vectors from Cell Nuclei from Monolayers and Histological Sections , 2001, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[4]  E. Kuipers,et al.  Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  E W Steyerberg,et al.  Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists , 2007, Histopathology.

[6]  M. O’Donovan,et al.  Non-endoscopic screening biomarkers for Barrett’s oesophagus: from microarray analysis to the clinic , 2009, Gut.

[7]  Kamran Ayub,et al.  NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma , 2007, PLoS medicine.

[8]  A. Weston,et al.  Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma , 1999, American Journal of Gastroenterology.

[9]  N. Nishioka,et al.  Novel endoscopic therapeutic modalities for superficial neoplasms arising in Barrett's esophagus: a primer for surgical pathologists , 2009, Modern Pathology.

[10]  L. Murray,et al.  The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. , 2008, American journal of epidemiology.

[11]  M S Pepe,et al.  Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.

[12]  Dennis M. Riehle,et al.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. , 2001, Gastroenterology.

[13]  W S Payne,et al.  The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. , 1985, The New England journal of medicine.

[14]  K Yogesan,et al.  Entropy-based texture analysis of chromatin structure in advanced prostate cancer. , 1996, Cytometry.

[15]  B. Overholt,et al.  Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.

[16]  M. Bronner,et al.  Poor Interobserver Agreement in the Distinction of High-Grade Dysplasia and Adenocarcinoma in Pretreatment Barrett's Esophagus Biopsies , 2008, The American Journal of Gastroenterology.

[17]  K. Raška,et al.  Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. , 1995, Cytometry.

[18]  B. Reid,et al.  Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis , 2010, Nature Reviews Cancer.

[19]  A. Reith,et al.  Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancer. , 1992, Cytometry.

[20]  E. Montgomery,et al.  Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. , 2001, Human pathology.

[21]  Fritz Albregtsen,et al.  Adaptive gray level run length features from class distance matrices , 2000, Proceedings 15th International Conference on Pattern Recognition. ICPR-2000.

[22]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[23]  K Yogesan,et al.  Nuclear texture analysis: a new prognostic tool in metastatic prostate cancer. , 1996, Cytometry.

[24]  Patricia L. Blount,et al.  Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.

[25]  J. Soares,et al.  Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved , 2007, Modern Pathology.

[26]  G. Haroske,et al.  Fourth Updated ESACP Consensus Report on Diagnostic DNA Image Cytometry , 2001, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[27]  Fritz Albregtsen,et al.  Low dimensional adaptive texture feature vectors from class distance and class difference matrices , 2004, IEEE Transactions on Medical Imaging.

[28]  Patricia L. Blount,et al.  Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables , 2001, American Journal of Gastroenterology.

[29]  Paul Fockens,et al.  Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  Fritz Albregtsen,et al.  A Review of Caveats in Statistical Nuclear Image Analysis , 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[31]  Hiroshi Mashimo,et al.  Radiofrequency ablation in Barrett's esophagus with dysplasia. , 2009, The New England journal of medicine.

[32]  M. Fernö,et al.  Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. , 1992, Cytometry.

[33]  Birgitte Nielsen,et al.  Prognostic Value of Adaptive Textural Features–The Effect of Standardizing Nuclear First-Order Gray Level Statistics and Mixing Information from Nuclei Having Different Area , 2006, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[34]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[35]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[36]  I Vergote,et al.  Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  M. Bronner,et al.  Grading of gastric foveolar-type dysplasia in Barrett's esophagus , 2010, Modern Pathology.

[38]  Fritz Albregtsen,et al.  Statistical nuclear texture analysis in cancer research: a review of methods and applications. , 2008, Critical reviews in oncogenesis.

[39]  Ben Davidson,et al.  Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer , 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[40]  P. Rabinovitch,et al.  Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy , 2010, British Journal of Cancer.

[41]  O. Cummings,et al.  Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. , 1999, Gastrointestinal endoscopy.

[42]  Carissa A. Sanchez,et al.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.

[43]  Carissa A. Sanchez,et al.  Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma , 2009, Clinical Cancer Research.

[44]  Carissa A. Sanchez,et al.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression , 2001, American Journal of Gastroenterology.